Mitochondria: A Therapeutic Target for Parkinson's Disease? - Test2 - elhamkhani - TriplyDB

Mitochondria: A Therapeutic Target for Parkinson's Disease?

Mitochondria: A Therapeutic Target for Parkinson's Disease?

http://www.wikidata.org/entity/Q26784216

about

Genome-wide analysis of DNA methylation during antagonism of DMOG to MnCl2-induced cytotoxicity in the mouse substantia nigra.Bile Acids in Neurodegenerative Disorders Network analysis of mitonuclear GWAS reveals functional networks and tissue expression profiles of disease-associated genes.Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson's disease model Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases.Protein undernutrition during development and oxidative impairment in the central nervous system (CNS): potential factors in the occurrence of metabolic syndrome and CNS disease.Overexpression of Annexin A1 Suppresses Pro-Inflammatory Factors in PC12 Cells Induced by 1-Methyl-4-Phenylpyridinium.Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner.Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis.Mitochondria in Ageing and Diseases: The Super Trouper of the Cell.Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson's disease.Alpha Lipoamide Ameliorates Motor Deficits and Mitochondrial Dynamics in the Parkinson's Disease Model Induced by 6-Hydroxydopamine.The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1.Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice.Mitochondria-targeted Probes for Imaging Protein Sulfenylation.The Role of Long Noncoding RNAs in Central Nervous System and Neurodegenerative Diseases

P2860

Q27334222-7F8DA5AD-8839-4EF7-A8F0-AC5BD11FF609 Q28078549-FF6465AE-2834-4C89-B20C-046AE935B059 Q37559800-D9A88C2A-75FD-4C44-9DFA-7F200B892FF4 Q37641524-0A2D4816-E6A6-4120-B61F-44206DD8000A Q38758318-53ABD363-5984-4A72-8E3D-0C6A49149F43 Q38824997-0A71D157-AC39-4383-8AD9-38CC115F70DA Q38857452-E09A45FD-282A-4A29-87AD-0E71AFAF0993 Q39474445-17150B1C-A8EF-4E17-8AE8-89E6369AC9FE Q41039539-96424E26-24D2-4EEC-8CD2-9723D5FD5B64 Q41565664-C02BB62C-7B51-4A93-9396-C2BE20F9553A Q42759561-56E49879-C1C9-47F1-BB15-BCC5902C6299 Q46537044-AED69A21-1DD5-4DD1-B9DF-3F8862DB9C40 Q47278911-33F380C0-3295-4ABD-8F16-BD69FCE653D1 Q47581099-047278BB-5985-40EE-8C18-BDE40181B613 Q52355227-B9095878-7EBF-42E2-AEF7-2EADBAA840D5 Q52676393-453786F1-506B-4EF2-8263-01762756C04B Q55114069-BFB31020-4D6F-4888-8073-DB5D9E10FE02 Q57490026-4EEBE9E5-0275-4CE1-BF6E-CC500127C230

P2860

Mitochondria: A Therapeutic Target for Parkinson's Disease?

http://www.wikidata.org/entity/Q26784216

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@ast

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@en

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@nl

type

label

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@ast

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@en

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@nl

prefLabel

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@ast

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@en

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@nl

P1433

Q26784216-4B02342A-45F4-4D3E-A39B-EAFF2402AAA6

P1476

Q26784216-253F1899-0E3C-480C-8B37-889611AD18B7

P2093

Q26784216-B42F7FE9-A355-4C08-B5DA-23ABB62C0398

Q26784216-D66579E7-DFA9-4044-9E0F-98A9452E6460

P275

Q26784216-5D886987-0A5C-48A9-83FD-6A342F2B9ECC

P2860

Q26784216-0247A303-8BB9-48DB-80C0-94DDF7146568

Q26784216-03ADAE22-0B40-42DD-AFA4-AFE444F17171

Q26784216-04AD4BD7-2A64-4F40-ADFB-086196A27451

Q26784216-085B4F7C-9A0E-4196-AAE5-FE82258E7821

Q26784216-08C1825F-3649-4150-9F29-A63120468981

Q26784216-09B2A3F7-AFC7-4979-A3D8-A463A978BB31

Q26784216-0CAC8FB6-438F-4D23-B2B3-03686336AA96

Q26784216-0DC33DEC-DB0F-405E-BF57-308E9F465430

Q26784216-0DE3B898-E70F-4354-A959-2965D2391241

Q26784216-0E06A521-D11E-4CD2-A9F0-CD55538F02E8

P304

Q26784216-0AFE7FA2-7824-4C33-AC36-82F86168B299

P31

Q26784216-0EDCE3C0-95CB-47F2-86D7-109E340A77C2

P3181

Q26784216-7088B4A1-5422-4667-BC95-598090D2A27D

P356

Q26784216-4D65ACDB-7F0B-46B0-BD1C-B8368AB173C6

P407

Q26784216-7D6FF8B9-A822-4236-B103-86C3853E5537

P433

Q26784216-CB32514E-DBDD-46D6-A65B-D4076936FF4A

P478

Q26784216-09056E02-D6CE-468F-8E63-6503712846B1

P50

Q26784216-887E5B27-864D-4CAC-BE2E-D317D8F4EA94

Q26784216-920A220F-410E-49CB-B200-BE345F506DBC

P5008

Q26784216-23B00B5D-67B6-4172-8078-A167F7DD02AA

P577

Q26784216-0D10E4FE-AF64-46E9-952E-85B23A1308DA

P5875

Q26784216-E7FBDF7E-E9E0-4BA1-9497-C32536B35678

P698

Q26784216-AE0506D1-3788-4569-B9C8-0203771F30E5

P921

Q26784216-36E65A39-D10B-4B30-82BC-C91336D7D3C7

Q26784216-4370D3CC-C4FC-4EF5-943F-5F223C86DC5D

Q26784216-4A24E29A-495D-4BD1-A311-D122A6C9A841

Q26784216-879D7187-F01C-4C61-8C1C-A8E964574DD0

Q26784216-FF023269-BC2E-4518-BEC2-FD42E2EAB93E

P932

Q26784216-2AB87EE7-3DEC-4A2F-A22C-70975292E87E

P3181

P356

P1433

International Journal of Molecular Sciences

P1476

Mitochondria: A Therapeutic Target for Parkinson's Disease?

@en

P2093

Alan Hoffer

http://www.w3.org/2001/XMLSchema#string

Barry Hoffer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP

Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation

PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1

p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both

Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells

AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1

Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons

P304

20704-20730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

226939

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/IJMS160920704

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281586513

http://www.w3.org/2001/XMLSchema#string

P698

26340618

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

Aagianik kimischri

P932

4613227

http://www.w3.org/2001/XMLSchema#string